Phase II study of the combination of docetaxel, cisplatin plus S-1(DCS) for advanced or recurrent gastric cancer(KDOG 0601)
Phase 2
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000001119
- Lead Sponsor
- Department of Gastroenterology, Kitasato University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients contraindicated to docetaxel,cisplatin,S-1 2)Active infection 3)Severe heart disease 4)Uncontrolled medical conditions (paralytic ileus,bowel obstruciton,interstitial pneumonia,pulmonary fibrosis,uncontrollable diabetes mellitus,renal failure,liver cirrhosis) 5)Massive abdominal effusion or massive pleural effusion 6)Extensive bone metastasis 7)Symptomatic brain metastasis 8)Severe diarrhea 9)Severe mental disorder 10)Histroy of other active malignancy 11)Pregnancy, the desire to preserve 12)Inadequate physical condition, as diagnosed by primary physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method